Navigation Links
BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
Date:10/28/2008

us T-cell lymphoma (CTCL) may not meet its endpoint, that development and commercialization of forodesine HCl in CTCL may not be successful, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates, that our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future preclinical and clinical development may not have positive results, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates, that our projected burn rate may not be consistent with our expectations, that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (File No. 333-145638), Quarterly Reports on Form 10-Q, current reports on Form 8-K which identify important factors that could cause the actual results to differ materially from those contained in the projections or forward-looking statements.

BCRXW


'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
2. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
3. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
4. LCA-Vision Reports Third Quarter 2008 Financial Results
5. Universal Health Services, Inc. Reports 2008 Third Quarter Results
6. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
7. Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009
8. WellPoint Reports Third Quarter 2008 Results
9. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
10. Schering-Plough Reports Financial Results for Third Quarter of 2008
11. Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... ... Sponsored by Gila River Casinos, the charity event helps raise funds and ... to the New Foundation AZ spokesperson , the organization is still looking for ... foursome for the tournament, as well as getting their company advertised on a banner ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... products, announces the Assisted Dumbbell Bench Rack, a fitness invention that eliminates the ... , "The Gym, Health and Fitness Clubs industry is worth $30 billion," says ...
(Date:8/4/2015)... ... August 04, 2015 , ... Exsurco Medical, ... of Tissue Banks (AATB) as an Affiliate Member. Exsurco Medical finds this ... to save and improve lives by promoting the safety, quality and availability of ...
(Date:8/4/2015)... ... ... assistPoint Partners, LLC is proud to announce a ... Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers together ... and workflow solution. This provides cancer center patient advocates, financial counselors and business ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Atlantic Health ... Great Place to Work® and Fortune among the top five in their list of ... organization of Morristown, Overlook, Newton and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:assistPoint.com Web Site Launched 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4
... to detect dementia so that it can be used ... test called National Institute //of Ageing's Consortium to Establish ... only ten minutes to administer. ,Researchers had focused ... stages often go undetected. They used a standardized diagnostic ...
... known that HIV patients are at an increased risk of ... shows // aggressive antiretroviral therapy may help lower that risk. ... therapy was associated with a lower incidence of Kaposi sarcoma ... more than 7,300 patients infected with HIV and the data ...
... reduction in inflammation can be achieved by a diet high ... such as salmon or mackerel. This is supported by the ... from an essential fatty acid in fish oil. ... fatty acids. Eating fatty fish is beneficial to patients with ...
... in the building behind me, starving to death, " Mark ... we smile together, and we talk together. She is my ... ,Members of the US Congress said on Saturday that ... at saving the life of Terri Schiavo, the brain damaged ...
... the drug rasagiline to standard treatment with levodopa can ... spend suffering from motor fluctuations they experience during the ... oral rasagiline to the drug entacapone, which must be ... around 690 patients. Both of the additional drugs were ...
... which examined the tobacco byproducts in the urine samples ... // themselves by thinking that they are getting fewer ... ,No significant difference was found in the amount ... the type of cigarettes they smoked nor there was ...
Cached Medicine News:
(Date:8/4/2015)... MOUNTAIN VIEW, Calif. , Aug. 4, 2015 /PRNewswire/ ... James H. Mackaness , who had served as ... officer since 2012, has resigned his positions with the ... financial officer position at another company. Mr. Mackaness intends ... the Company,s second quarter earnings announcement and 10-Q filing. ...
(Date:8/4/2015)... , Aug. 4, 2015 Governor Tom Wolf ... company that develops and markets implants in the spine and ... Hanover Township , Northampton County ... move that will create 25 new, full-time jobs. ... and create more than two dozen, high-paying jobs ...
(Date:8/4/2015)... , Aug. 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: ... , M.B., Ch.B., Sangamo,s executive vice president, research and ... Sangamo,s ZFP Therapeutic ® development programs and an ... on Tuesday, August 11, 2015, at the 2015 Wedbush ... New York, NY . ...
Breaking Medicine Technology:IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2
... demand for medical devices,has been increasing in recent ... is so high because local manufacturers concentrate mainly ... in most,Russian hospitals and clinics are obsolete and ... attractive also for foreign manufacturers. , ...
... FORD, Pa., Jan. 29 Endo Pharmaceuticals (Nasdaq: ... it has concluded its research collaboration with Alexza Pharmaceuticals, ... inhaled fentanyl product for the treatment of breakthrough pain ... fentanyl (AZ-003/EN-3284), has completed Phase I clinical testing and ...
Cached Medicine Technology:Foreign Medical Devices are in High Demand in Russia 2Foreign Medical Devices are in High Demand in Russia 3Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 2Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 3
... Tupper's Universal Hand Holder and ... fixate the hand in any position ... with skin or tendon hooks, fixate ... Holder. With the patient's hand held ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
... iso-centered c-arm with its integrated ... to position in the sterile ... x-ray tube head, three position ... control provide convenient access to ...
... The SmartPLUG from Medennium is ... the "punctum" or tear duct, and ... is designed to fit a range ... flexible thermosensitive acrylic material, SmartPLUG adjusts ...
Medicine Products: